WARNING!
This is an older article that may not reflect Dr. Mercola’s current view on this topic. Use our search engine to find Dr. Mercola’s latest position on any health topic.
GlaxoSmithKline is preparing to sell billions worth of swine flu drugs this year. Their swine flu vaccine will be available by September, and international governments are already stockpiling large supplies of GSK's anti-viral treatment Relenza.
Worldwide sales from the two drugs are expected to be enormous, but the company rejected claims it was exploiting the pandemic.